| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Department of Bioengineering and McGowan Institute for Regenerative Medicine, University of Pittsburgh; 2 Department of Medicine and 3 Cardiovascular Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; 4 Roswell Park Cancer Institute, Buffalo, New York; and 5 Cardiovascular Imaging Center, University of Virginia, Charlottesville, Virginia
Requests for reprints: Flordeliza Villanueva, Cardiovascular Institute, University of Pittsburgh, S-568 Scaife Hall, 200 Lothrop Street, Pittsburgh, PA 15213. Phone: 412-647-5840; Fax: 412-647-4227; E-mail: villanuevafs{at}msx.upmc.edu.
Endothelial cells (EC) of angiogenic tumor vasculature are characterized by altered expression of molecular markers on their surface. Numerous peptides have been identified that specifically bind tumor angiogenic endothelium, including the tripeptide arginine-arginine-leucine (RRL). We hypothesized that ultrasound contrast microbubbles (MB) targeted via linkage with RRL would specifically adhere to tumor angiogenic endothelium versus normal myocardium, and that this selective adhesion could be detected ultrasonically. Microbubbles were conjugated to cyclic peptides containing either RRL (RRL-MB) or a glycine control sequence (control-MB). As measured in a parallel plate flow chamber, in vitro adhesion of RRL-MBs was three times greater to cultured tumor–derived ECs than to normal ECs (P < 0.01), demonstrating selective binding of RRL-MBs to tumor endothelium. Mice bearing s.c. Clone C or PC3 tumors were given i.v. injections of fluorescent RRL to show in vivo localization to tumor vasculature or were ultrasonically imaged following i.v. injections of targeted contrast MBs. Ultrasound images showed strong RRL-MB contrast enhancement within the tumors but not the control tissue myocardium. Control-MBs caused minimal enhancement in either tissue. Quantitative acoustic videointensity was significantly greater for the tumors than the hearts (5 ± 1 versus 0.5 ± 1 intensity units; P = 0.001). These data show that ultrasound contrast MBs targeted to tumor vasculature via RRL preferentially adhere to tumor versus normal vasculature and that this selective adherence can be detected with ultrasound. Targeted microbubbles may thus offer a noninvasive contrast-enhanced ultrasound imaging technique for the functional imaging of tumor neovascularization, and may have further implications for therapeutic tumor targeting.
Key Words: Targeting • Tumor • Angiogenesis • Molecular Imaging • Ultrasound
This article has been cited by other articles:
|
|
 |
|
  H. Leong-Poi Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy Cardiovasc Res, November 1, 2009; 84(2): 190 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Barreiro, R. J. Aguilar, E. Tejera, D. Megias, F. de Torres-Alba, A. Evangelista, and F. Sanchez-Madrid Specific Targeting of Human Inflamed Endothelium and In Situ Vascular Tissue Transfection by the Use of Ultrasound Contrast Agents J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 997 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler Multimodality Cardiovascular Molecular Imaging, Part I Circ Cardiovasc Imaging, November 1, 2008; 1(3): 244 - 256. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jimenez, R. de Gracia, A. Aguilera, S. Alonso, A. Cirugeda, J. Benito, R. M. Regojo, R. Aguilar, A. Warlters, R. Gomez, et al. In Situ Kidney Insonation With Microbubble Contrast Agents Does Not Cause Renal Tissue Damage in a Porcine Model J. Ultrasound Med., November 1, 2008; 27(11): 1607 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Willmann, Z. Cheng, C. Davis, A. M. Lutz, M. L. Schipper, C. H. Nielsen, and S. S. Gambhir Targeted Microbubbles for Imaging Tumor Angiogenesis: Assessment of Whole-Body Biodistribution with Dynamic Micro-PET in Mice Radiology, October 1, 2008; 249(1): 212 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Willmann, A. M. Lutz, R. Paulmurugan, M. R. Patel, P. Chu, J. Rosenberg, and S. S. Gambhir Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo Radiology, September 1, 2008; 248(3): 936 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Willmann, R. Paulmurugan, K. Chen, O. Gheysens, M. Rodriguez-Porcel, A. M. Lutz, I. Y. Chen, X. Chen, and S. S. Gambhir US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice Radiology, February 1, 2008; 246(2): 508 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lyshchik, A. C. Fleischer, J. Huamani, D. E. Hallahan, M. Brissova, and J. C. Gore Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast-Enhanced High-Frequency Ultrasonography J. Ultrasound Med., November 1, 2007; 26(11): 1575 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Villanueva, E. Lu, S. Bowry, S. Kilic, E. Tom, J. Wang, J. Gretton, J. J. Pacella, and W. R. Wagner Myocardial Ischemic Memory Imaging With Molecular Echocardiography Circulation, January 23, 2007; 115(3): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Korpanty, J. G. Carbon, P. A. Grayburn, J. B. Fleming, and R. A. Brekken Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature Clin. Cancer Res., January 1, 2007; 13(1): 323 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Pacella and F. S. Villanueva Effect of Coronary Stenosis on Adjacent Bed Flow Reserve: Assessment of Microvascular Mechanisms Using Myocardial Contrast Echocardiography Circulation, October 31, 2006; 114(18): 1940 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Pacella, M. V. Kameneva, M. Csikari, E. Lu, and F. S. Villanueva A novel hydrodynamic approach to the treatment of coronary artery disease Eur. Heart J., October 1, 2006; 27(19): 2362 - 2369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kruskal Will Improved Assessment of Response to Antiangiogenic Therapies Be Achieved with Contrast-enhanced Gray-Scale US? Radiology, July 1, 2006; 240(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
F. S. Villanueva Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function? Circulation, June 21, 2005; 111(24): 3188 - 3191. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
